Cargando…
Intravenous Administration of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α Completely Regressed Solid Tumor in Meth‐A Murine Sarcoma Model
Complete regression of solid tumors was achieved by plural intravenous (i.v.) administrations of polyethylene glycol (PEG)‐modified tumor necrosis factor‐a (TNF‐α), prepared by covalently modifying natural human TNF‐α with N‐succinimidyl succinate PEG. The anti‐tumor efficacy of PEG‐modifled TNF‐α (...
Autores principales: | Tsutsumi, Yasuo, Kihira, Tetsunari, Tsunoda, Shin‐ichi, Kubo, Kazuyoshi, Miyake, Masaharu, Kanamori, Toshhiori, Nakagawa, Shinsaku, Mayumi, Tadanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919383/ https://www.ncbi.nlm.nih.gov/pubmed/7852179 http://dx.doi.org/10.1111/j.1349-7006.1994.tb02926.x |
Ejemplares similares
-
Chemical Modification of Natural Human Tumor Necrosis Factor‐α with Polyethylene Glycol Increases Its Anti‐tumor Potency
por: Tsutsumi, Yasuo, et al.
Publicado: (1994) -
In vivo Anti‐tumor Efficacy of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α against Tumor Necrosis Factor‐resistant Tumors
por: Tsutsumi, Yasuo, et al.
Publicado: (1996) -
Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency.
por: Tsutsumi, Y., et al.
Publicado: (1995) -
Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency.
por: Tsutsumi, Y., et al.
Publicado: (1996) -
Preferential Activity of Wild‐type and Mutant Tumor Necrosis Factor‐α against Tumor‐derived Endothelial‐like Cells
por: Kuroda, Kensei, et al.
Publicado: (2000)